FDA Transparency Task Force Releases 21 Proposals

On May 19 the Transparency Task Force of the U.S. Food and Drug Administration released a report containing 21 draft proposals about expanding the disclosure of information by FDA while maintaining confidentiality for trade secrets and individually identifiable patient information. The FDA is accepting public comment regarding the content of the proposals, as well as on which draft proposals should be given priority, on its website until July 20. The FDA notes that not all its proposals will necessarily be implemented because some may require changes in law or regulation and some may require substantial amounts of resources.